HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bilateral anterior thalamic nucleus lesions are not protective against seizures in chronic pilocarpine epileptic rats.

AbstractAIMS:
To investigate whether anterior thalamic nucleus (AN) lesions are protective against spontaneous recurrent seizures in the chronic phase of the pilocarpine model of epilepsy.
METHODS:
Two groups of rats were treated with bilateral AN radiofrequency thalamotomies or sham surgery 2 weeks after pilocarpine-induced status epilepticus. After the lesions, animals were videotaped from the 2nd to the 8th week after status epilepticus (total 180 h).
RESULTS:
During the 6 weeks of observation, no differences in the frequency of spontaneous seizures were found between animals that had bilateral AN lesions (n = 26; 3.1 +/- 0.6 seizures per animal) and controls (n = 25; 3.0 +/- 0.6 seizures per animal; p = 0.8).
CONCLUSIONS:
We conclude that AN thalamotomies were not effective in reducing the frequency of seizures during the chronic phase of the pilocarpine model of epilepsy.
AuthorsClement Hamani, Flavio I S Ewerton, Flávia Marcolin de Almeida, Saulo M Bonilha, Luciene Covolan, Clarissa Fantin Cavarsan, Gerson Ballester, Luiz E Mello, Andres M Lozano
JournalStereotactic and functional neurosurgery (Stereotact Funct Neurosurg) Vol. 87 Issue 3 Pg. 143-7 ( 2009) ISSN: 1423-0372 [Electronic] Switzerland
PMID19321966 (Publication Type: Comparative Study, Journal Article)
Copyright2009 S. Karger AG, Basel.
Chemical References
  • Pilocarpine
Topics
  • Animals
  • Anterior Thalamic Nuclei (pathology, surgery)
  • Epilepsy (chemically induced, pathology, surgery)
  • Male
  • Pilocarpine (administration & dosage, toxicity)
  • Rats
  • Rats, Wistar
  • Seizures (chemically induced, prevention & control, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: